Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Shijin Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100836552. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

  1. Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013269↗
  2. Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12951-025-03795-z↗
  3. CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202305279↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shu Zhang · 3 shared papers, 2024–2025 · strength 0.58
  2. Yixuan Zhang · 2 shared papers, 2025 · strength 0.40
  3. Ying Lv · 2 shared papers, 2025 · strength 0.40
  4. Jiajun Zhang · 1 shared paper, 2025 · strength 0.21
  5. Ziwei Zhang · 1 shared paper, 2025 · strength 0.21
  6. Li Lin · 1 shared paper, 2025 · strength 0.21
  7. Lei Wang · 1 shared paper, 2025 · strength 0.19
  8. Jiatong Tang · 1 shared paper, 2025 · strength 0.19
  9. Xiaoping Zou · 1 shared paper, 2025 · strength 0.19
  10. Qi Li · 1 shared paper, 2025 · strength 0.19
  11. Ying Lv · 1 shared paper, 2024 · strength 0.18
  12. Yixuan Zhang · 1 shared paper, 2024 · strength 0.18
  13. Zhang Yin · 1 shared paper, 2024 · strength 0.18
  14. Xiaoping Zou · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.